Profiel
Linda Shi is currently the Chief Medical Officer & Deputy President at Grand Pharma (China) Co., Ltd. Prior to this, she served as the Chairman at OncoSec Medical, Inc. from 2021 to 2023.
She also held the position of Executive Director at Grand Pharmaceutical Group Ltd. from 2021 to 2024.
Dr. Shi obtained her doctorate degree from Vrije Universiteit Brussel in 2005.
Actieve functies van Linda Shi
| Bedrijven | Functie | Begin |
|---|---|---|
Grand Pharma (China) Co., Ltd.
Grand Pharma (China) Co., Ltd. BiotechnologyHealth Technology Operates as a holding company whose subsidiaries engages in research and development of drugs, manufacturing & sale of pharmaceutical preparations | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Linda Shi
| Bedrijven | Functie | Einde |
|---|---|---|
| GRAND PHARMACEUTICAL GROUP LIMITED | Directeur/Bestuurslid | 24-06-2024 |
| ONCOSEC MEDICAL INCORPORATED | Voorzitter | 14-06-2023 |
Opleiding van Linda Shi
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
OncoSec Medical, Inc.
OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
Vrije Universiteit Brussel
Vrije Universiteit Brussel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Grand Pharmaceutical Group Ltd.
Grand Pharmaceutical Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical and health products | Health Technology |
Grand Pharma (China) Co., Ltd.
Grand Pharma (China) Co., Ltd. BiotechnologyHealth Technology Operates as a holding company whose subsidiaries engages in research and development of drugs, manufacturing & sale of pharmaceutical preparations | Health Technology |
















